RxDoctor Payments DataLook up a doctor →

Gathline Etienne, MD

Neurology · Newnan, GANPI 1366602005

Payments from drug & device makers

$128,187in general payments, 2019–2025

Across 482 payments — averaging $265.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$67K
  • AstraZeneca$30K
  • Biogen$26K
  • Argenx US, Inc.$1K
  • Novartis$457
  • UCB, Inc.$417
  • plus $3K from 49 others

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)150$66,999
AstraZeneca(2 entities)42$29,589
Biogen61$26,398
Argenx US, Inc.3$1,206
Novartis42$457
UCB, Inc.22$417
Amgen(2 entities)13$248
SK Life Science, Inc.3$226
Sanofi9$170
Greenwich Biosciences, Inc.6$160
Avanir Pharmaceuticals, Inc.11$149
Teva Pharmaceuticals USA, Inc.8$145
Lilly USA, LLC8$134
Lundbeck LLC6$124
Harmony Biosciences LLC3$105
Acadia Pharmaceuticals Inc6$102
Genentech USA, Inc.5$99
MDD US Operations, LLC5$87
Bausch Health US, LLC4$84
Upsher-smith Laboratories LLC4$77
Eisai Inc.5$77
Amneal Pharmaceuticals LLC5$73
Supernus Pharmaceuticals, Inc.5$67
Acorda Therapeutics, Inc3$63
Adamas Pharmaceuticals, Inc.4$62
CSL Behring2$56
Takeda Pharmaceuticals U.S.A., Inc.3$51
Johnson & Johnson2$45
Grifols USA, LLC3$43
GE HealthCare3$39
Zyla Life Sciences, Inc.3$37
Endo Pharmaceuticals Inc.2$36
Assertio Therapeutics, Inc.2$35
Akcea Therapeutics, Inc.2$34
Neurelis, Inc.2$34
Vertical Pharmaceuticals, LLC2$34
ANI Pharmaceuticals, Inc.2$33
Mallinckrodt Enterprises LLC2$32
Kyowa Kirin, Inc.2$31
Neurocrine Biosciences, Inc.1$30
EMD Serono, Inc.2$29
Banner Life Sciences, LLC1$27
Scilex Pharmaceuticals Inc.1$23
Mallinckrodt Hospital Products Inc.1$22
Aprecia Pharmaceuticals, LLC1$22
Corium, LLC1$21
Biohaven Pharmaceutical Holding Company Ltd.1$20
W. L. Gore & Associates, Inc.1$19
Otsuka America Pharmaceutical, Inc.1$19
TG Therapeutics, Inc.1$18
Jazz Pharmaceuticals Inc.1$18
Pfizer1$18
Shire North American Group Inc1$16
GRT US Holding, Inc.1$16
Almatica Pharma LLC1$12

How this compares

$128,187 in reported general payments places this provider in the 90th percentile of 506 neurology providers in Georgia.

See all neurology providers in Georgia →

Medicare billing

Part B allowed, 2024
$18,010
Medicare patients
137
Services billed
195

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Newnan

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →